PPCB vs UPS · P/E 0.0, $3.9M cap vs P/E 15, rev $88.66B
Propanc Biopharma, Inc. Common Stock (PPCB) versus United Parcel Service Inc (UPS) — a side-by-side from cached financials, not a winner call.
Propanc Biopharma, Inc. Common Stock (PPCB) is a biotechnology company listed on NASDAQ.
United Parcel Service Inc (UPS) is a integrated freight & logistics company listed on US.
PPCB does not have a complete income-statement cache yet.
Latest reported UPS revenue for 2025-12-31 was $88.66B. Net income was $5.57B. Revenue was down 2.6% from 2024-12-31 to 2025-12-31. UPS currently screens at market cap $85.76B and trailing P/E 14.8.
PPCB currently screens at market cap $3.9M and trailing P/E 0.0. UPS currently screens at market cap $85.76B and trailing P/E 14.8.
Not investment advice. Open the PPCB and UPS stock pages for the full models.
Not investment advice.